Pharmabiz38m
Ironwood Pharma begins apraglutide NDA filing to treat patients with short bowel syndrome
Ironwood Pharma begins apraglutide NDA filing to treat patients with short bowel syndrome: Boston Friday, January 31, 2025, 13:00 Hrs [IST] Ironwood Pharmaceuticals, Inc, a biotec ...
Pharmabiz2h
Biocon in Q3FY25 generated revenue of Rs. 3,856 crore, net profit at Rs. 25 crore
Our Bureau, Bengaluru Friday, January 31, 2025, 11:30 Hrs [IST] ...
Pharmabiz2h
Olympus issues medical device advisory notice to use alternative devices to the MAJ-891 accessory
Olympus issues medical device advisory notice to use alternative devices to the MAJ-891 accessory: Center Valley, Pennsylvania Friday, January 31, 2025, 11:00 Hrs [IST] Olympus Co ...
Pharmabiz3h
Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis
Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...
Pharmabiz4h
Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody
Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...
Pharmabiz5h
Industry urges govt to reduce API dependency & increase healthcare spending to 3% of GDP in Budget 2025
Shardul Nautiyal, Mumbai Friday, January 31, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
It was too difficult to convince professionals about Pharm D in the beginning: Dr B Suresh
Peethaambaran Kunnathoor, Chennai Friday, January 31, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Healthcare sector faces challenges in leprosy elimination with hidden cases & delayed detection
Healthcare sector faces challenges in leprosy elimination with hidden cases & delayed detection: Nandita Vijayasimha, Bengaluru Friday, January 31, 2025, 08:00 Hrs [IST] Indian he ...
Pharmabiz5h
India poised to revolutionize global genetic testing: Dr Geethika Nutakki
Dr Geethika Nutakki: Shardul Nautiyal, Mumbai Friday, January 31, 2025, 08:00 Hrs [IST] India is on the brink of a healthcare ...
Pharmabiz19h
X-CIPLOG 2025 Reunion and Awards reflects industry excellence, resonates with Government Padma honour to pharma industry
Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...
Pharmabiz20h
March Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
Pharmabiz21h
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...